CERECOR INC COMMON (CERC) Covered Calls

You can sell covered calls on CERECOR INC COMMON to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CERC (prices last updated Mon 4:16 PM ET):

CERECOR INC COMMON (CERC) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
4.59 -0.03 4.44 4.62 88K 11 0.2B
Covered Calls For CERECOR INC COMMON (CERC)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Oct 19 5 0.00 4.62 0.0% 0.0%
Nov 16 5 0.20 4.42 4.5% 49.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Cerecor Inc., a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Veripred, and Ulesfia for the treatment of inflammation of the skin, joints, lungs, and other organs, as well as asthma, allergies, arthritis, and head lice infestation. It also offers Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension; and Flexichamber. The company is developing CERC-301, an orphan neurological indication for controlling neurologic adaptation; CERC-611, a drug candidate for the treatment of partial-onset seizures in epilepsy; and two preclinical stage development candidates, CERC-406 and CERC-425 potential for the treatment of motoric and non-motoric symptoms of Parkinson's disease, as well as other psychiatric and neurological conditions. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Baltimore, Maryland.